Patent · US Active

Compositions and methods for treating cancer

US11534420B2 · kind B2 · utility

0Cited by
33References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 14, 2020
Grant dateDec 27, 2022
Priority date
Expiry dateMay 14, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are methods for treating cancer by reduction of glycogen stores and administering tyrosine derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.